Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LP-003 in Wheat Allergy
NCT07816432Phase 2Not yet recruiting
- Sponsor
- LongBio Pharma
- Start
- Sep 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 2 trial of LP-003 in wheat allergy, sponsored by LongBio Pharma. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
LP-003
03
Conditions
wheat allergy
Beyond the preview
Go deeper on NCT07816432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07816432.